LymphaTouch Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • LymphaTouch's estimated annual revenue is currently $3M per year.(i)
  • LymphaTouch's estimated revenue per employee is $251,000

Employee Data

  • LymphaTouch has 12 Employees.(i)
  • LymphaTouch grew their employee count by 0% last year.

LymphaTouch's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M40-18%$10MN/A
#2
$24.8M9929%N/AN/A
#3
$84.1M0N/A$1.2MN/A
#4
$35.6M14230%N/AN/A
#5
$57.5M2296%N/AN/A
#6
$52.7M16825%$129.6MN/A
#7
$21.1M84-3%N/AN/A
#8
$61.2M244-13%N/AN/A
#9
$60.6M19320%$115.5MN/A
#10
$56.2M179-3%$122.9MN/A
Add Company

What Is LymphaTouch?

LymphaTouch Inc. is a pioneering Finnish healthcare technology company developing treatment device based on negative pressure. LymphaTouch Inc. was originally developed in 2005. The first device was developed for physiotherapy and rehabilitation professionals to support lymphedema treatment. Our LymphaTouch device, previously also known as PhysioTouch, has been successfully used among physiotherapy, lymph therapy and rehabilitation, to help treating swelling and edema, and promoting faster recovery for patients. LymphaTouch is already used worldwide. The goal of our company is to promote treatment that is based on scientific evidence, and benefits patients, caregivers and the healthcare society. Our Mission Create innovative therapeutic solutions to improve patient lives Our Vision Leading manufacturer of professional therapeutic devices for oncology, orthopaedic, sports, neurology, and MSD Our values are: • Integrity – we run our business with honesty and high integrity • Passion – we simply love what we do • Happiness – we create positive and inspiring environment • Commitment – we are committed to high quality and customer focus • Growth – we grow profitably and encourage individual development LymphaTouch Inc. is ISO 9001:2008 and ISO 13485:2003 certified. Our products are manufactured in Finland and are CE marked in accordance with directive 93/42/EEC. LymphaTouch is also FDA Class 1 Exempt device.

keywords:N/A

N/A

Total Funding

12

Number of Employees

$3M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.8M120%N/A
#2
$1.8M120%N/A
#3
$1M1220%N/A
#4
$1.6M12-14%N/A
#5
$1M12N/AN/A